Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension
暂无分享,去创建一个
T. Renné | U. Walter | A. Gruber | K. Lackner | T. Münzel | B. Monia | A. Daiber | K. Jurk | W. Ruf | M. Oelze | C. Reinhardt | N. Xia | M. Knorr | P. Wenzel | Z. Ruggeri | Huige Li | M. Brandt | J. Lagrange | S. Karbach | T. Schönfelder | S. Jäckel | Sabine Kossmann | Moritz Ehlken | Yvonne Weihert | Sven Jäckel | Tanja Schönfelder
[1] D. Harats,et al. Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[2] W. Schaper,et al. Critical Role of Platelet Glycoprotein Ib&agr; in Arterial Remodeling , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[3] B. Lee,et al. Cluster of Differentiation 43 Deficiency in Leukocytes Leads to Reduced Atherosclerosis—Brief Report , 2015, Arteriosclerosis, Thrombosis and Vascular Biology.
[4] G. Raskob,et al. Factor XI antisense oligonucleotide for prevention of venous thrombosis. , 2014, The New England journal of medicine.
[5] C. Meyer-Schwesinger,et al. Myeloperoxidase deficiency ameliorates progression of chronic kidney disease in mice. , 2014, American journal of physiology. Renal physiology.
[6] S. Russell,et al. Platelet Glycoprotein Ib-IX as a Regulator of Systemic Inflammation , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[7] B. Monia,et al. Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits. , 2014, Blood.
[8] A. Gruber,et al. Contributions of thrombin targets to tissue factor‐dependent metastasis in hyperthrombotic mice , 2014, Journal of thrombosis and haemostasis : JTH.
[9] J. Pollock,et al. Differential regulation of nitric oxide synthase function in aorta and tail artery from 5/6 nephrectomized rats , 2013, Physiological reports.
[10] T. Münzel,et al. Angiotensin II–Induced Vascular Dysfunction Depends on Interferon-&ggr;–Driven Immune Cell Recruitment and Mutual Activation of Monocytes and NK-Cells , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[11] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[12] B. Engelmann,et al. Thrombosis as an intravascular effector of innate immunity , 2012, Nature Reviews Immunology.
[13] Alan D. Lopez,et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[14] F. Luft,et al. Immune mechanisms in angiotensin II-induced target-organ damage , 2012, Annals of medicine.
[15] O. McCarty,et al. Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis. , 2012, Blood.
[16] M. Port,et al. Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide , 2012, British journal of pharmacology.
[17] J. Nofer,et al. Extracellular protein disulfide isomerase regulates feedback activation of platelet thrombin generation via modulation of coagulation factor binding , 2011, Journal of thrombosis and haemostasis : JTH.
[18] A. Waisman,et al. Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction , 2011, Circulation.
[19] A. Gruber,et al. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. , 2011, The Journal of clinical investigation.
[20] B. Monia,et al. Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. , 2010, Blood.
[21] D. Steinberg,et al. Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis , 2010, Thrombosis and Haemostasis.
[22] E. Ringelstein,et al. Activated monocytes capture platelets for heterotypic association in patients with severe carotid artery stenosis , 2010, Thrombosis and Haemostasis.
[23] P. Libby,et al. Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.
[24] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.
[25] O. McCarty,et al. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. , 2009, Blood.
[26] D. Tanné,et al. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. , 2008, Blood.
[27] J. Rosing,et al. Development of a calibrated automated thrombography based thrombin generation test in mouse plasma , 2007, Journal of thrombosis and haemostasis : JTH.
[28] D. Harrison,et al. Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction , 2007, The Journal of experimental medicine.
[29] P. Libby,et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. , 2007, The Journal of clinical investigation.
[30] R. Burger,et al. Use of a dummy (pacifier) during sleep and risk of sudden infant death syndrome (SIDS): population based case-control study , 2005, BMJ : British Medical Journal.
[31] D. Simon,et al. Leukocyte Engagement of Platelet Glycoprotein Ibα via the Integrin Mac-1 Is Critical for the Biological Response to Vascular Injury , 2005, Circulation.
[32] L. Silengo,et al. Protection from angiotensin II–mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ , 2005, The Journal of experimental medicine.
[33] P. Walsh,et al. Factor XI Interacts with the Leucine-rich Repeats of Glycoprotein Ibα on the Activated Platelet* , 2004, Journal of Biological Chemistry.
[34] P. Walsh,et al. Identification of a Binding Site for Glycoprotein Ibα in the Apple 3 Domain of Factor XI* , 2004, Journal of Biological Chemistry.
[35] T. Renné,et al. Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo , 2004, Thrombosis and Haemostasis.
[36] L. Gesualdo,et al. jun-N-terminal kinase regulates thrombin-induced PAI-1 gene expression in proximal tubular epithelial cells. , 2004, Kidney international.
[37] H. Hemker,et al. Factor XI–Dependent Reciprocal Thrombin Generation Consolidates Blood Coagulation when Tissue Factor Is Not Available , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[38] A. Takeshita,et al. Critical Role of Monocyte Chemoattractant Protein-1 Receptor CCR2 on Monocytes in Hypertension-Induced Vascular Inflammation and Remodeling , 2004, Circulation research.
[39] H. Hemker,et al. Initiating and potentiating role of platelets in tissue factor‐induced thrombin generation in the presence of plasma: subject‐dependent variation in thrombogram characteristics , 2004, Journal of thrombosis and haemostasis : JTH.
[40] D. Sheppard,et al. Transforming Growth Factor-β-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in β6−/− Mice , 2003 .
[41] J. Ware,et al. Modulation of α-Thrombin Function by Distinct Interactions with Platelet Glycoprotein Ibα , 2003, Science.
[42] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[43] T. Kanaji,et al. Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome. , 2002, Blood.
[44] D. Monroe,et al. Platelets and thrombin generation. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[45] E. Rosen,et al. FXI Is Essential for Thrombus Formation Following FeCl3-Induced Injury of the Carotid Artery in the Mouse , 2002, Thrombosis and Haemostasis.
[46] R. Busse,et al. Thrombin Activates the Hypoxia-Inducible Factor-1 Signaling Pathway in Vascular Smooth Muscle Cells: Role of the p22phox-Containing NADPH Oxidase , 2001, Circulation research.
[47] J. Esplugues,et al. Angiotensin II Induces Leukocyte–Endothelial Cell Interactions In Vivo Via AT1 and AT2 Receptor–Mediated P-Selectin Upregulation , 2000, Circulation.
[48] L. McIntire,et al. Platelet Glycoprotein Ibα Is a Counterreceptor for the Leukocyte Integrin Mac-1 (Cd11b/Cd18) , 2000, The Journal of experimental medicine.
[49] P. Bongrand,et al. Thrombin-Activated Human Endothelial Cells Support Monocyte Adhesion In Vitro Following Expression of Intercellular Adhesion Molecule-1 (ICAM-1; CD54) and Vascular Cell Adhesion Molecule-1 (VCAM-1; CD106) , 1998 .
[50] V. Grau,et al. Rat monocytes up‐regulate NKR‐P1A and down‐modulate CD4 and CD43 during activation in vivo: monocyte subpopulations in normal and IFN‐γ‐treated rats , 1997 .
[51] C. Gahan,et al. Innate resistance to Listeria monocytogenes in tumor‐bearing mice , 1997, Journal of Leukocyte Biology.
[52] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[53] G. Broze,et al. A murine model of factor XI deficiency. , 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[54] D. Harrison,et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.
[55] A. J. Valente,et al. Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. , 1995, Circulation research.
[56] A. Guha,et al. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. , 1993, Journal of Clinical Investigation.
[57] G. Broze,et al. Factor XI activation in a revised model of blood coagulation , 1991, Science.
[58] M. Elices,et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.
[59] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[60] M. Kahn. A critical role of platelet glycoprotein Ibα in arterial remodeling. , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[61] P. Kirchhof,et al. The task force for the management ofarterial hypertension of the european society ofhypertension (esh) and of the european society of cardiology (esc) , 2013 .
[62] Jeroen J. Bax,et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.
[63] M. Roizen. Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-analysis of Randomized Controlled Trials , 2007 .
[64] H. Hemker,et al. Thrombin generation, a function test of the haemostaticthrombotic system , 2006, Thrombosis and Haemostasis.